نتایج جستجو برای: mibg therapy

تعداد نتایج: 654606  

Journal: :Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009
Jacek Toporski Michael Garkavij Jan Tennvall Ingrid Ora Katarina Sjögreen Gleisner Josefina H Dykes Stig Lenhoff Gunnar Juliusson Stefan Scheding Dominik Turkiewicz Albert N Békássy

We evaluated the feasibility and efficacy of using high-dose iodine-131-metaiodobenzylguanidine ((131)I-MIBG) followed by reduced-intensity conditioning (RIC) and transplantation of T cell-depleted haploidentical peripheral blood stem cells (designated haplo-SCT) to treat relapsing/refractory neuroblastoma (RRNB). Five RRNB patients were enrolled: 4 with relapse (3 after autologous SCT) and 1 w...

Journal: :Research, Society and Development 2023

Objetivo: Avaliar se a radioiodoterapia com 131I-metaiodobenzilguanidina (131I-mIBG) aumenta sobrevida de pacientes diagnóstico neuroblastoma, mIBG-ávido, refratários ao tratamento ou alto risco para recidiva, independentemente do estadiamento da doença. Métodos: Revisão sistemática literatura. Consultadas as bases Medline (PUBMED), EMBASE e Cochrane Library, sendo incluídos estudos disponíveis...

Journal: :Cancer research 1989
L A Smets C Loesberg M Janssen E A Metwally R Huiskamp

Radio-iodinated m-iodobenzylguanidine (MIBG), an analogue of the neurotransmitter norepinephrine (NE), is increasingly used in the diagnosis and treatment of neural crest tumors. Active uptake and subsequent retention of MIBG and NE was studied in human neuroblastoma SK-N-SH cells. Neuron-specific uptake of [125I]MIBG and [3H]NE saturated at extracellular concentration of 10(-6) M and exceeded ...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009
Susan E Buckley Sarah J Chittenden Frank H Saran Simon T Meller Glenn D Flux

UNLABELLED The aims of this study were to examine the relationship between whole-body absorbed dose and hematologic toxicity and to assess the most accurate method of delivering a prescribed whole-body absorbed dose in (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy for neuroblastoma. METHODS A total of 20 children (1-12 y), 5 adolescents (13-17 y), and 1 adult (20 y) with stage 3 or 4 n...

Journal: :Annals of nuclear medicine 2004
Junichi Taki Mitsuhiro Yoshita Masahito Yamada Norihisa Tonami

Recently, reliable and clear evidence for the usefulness of 123I-MIBG scintigraphy in the diagnosis of Parkinson's disease (PD) has been accumulated and it has become increasingly popular as one of the most accurate means of diagnosing the disease. PD, one of the most common neurodegenerative disorders, is characterized by resting tremor, rigidity, bradykinesia or akinesia, and postural instabi...

Introduction: The present study was aimed to assess the diagnostic performance of the two imaging methods of 131I-metaiodobenzylguanidine (131I-MIBG) and 99mTc-hydrazinonicotinyl-Tyr3-Octreotide (99mTc-HYNIC-TOC) in diagnosis and localization of pheochromocytoma and neuroblastoma. Methods: This study ...

2002
Masato Furuhashi

(I-MIBG) Imaging in Brugada Syndrome To the Editor: We read with interest a recent article in Circulation by Wichter et al1 on cardiac autonomic dysfunction in Brugada syndrome. The authors demonstrated that regionally reduced iodine-123-metaiodobenzylguanidine (I-MIBG) uptake in the inferior and septal left ventricular wall was present in 8 (47%) of 17 patients with Brugada syndrome but in non...

Journal: :Circulation 2002
Masato Furuhashi Kikuya Uno Kazufumi Tsuchihashi

(I-MIBG) Imaging in Brugada Syndrome To the Editor: We read with interest a recent article in Circulation by Wichter et al1 on cardiac autonomic dysfunction in Brugada syndrome. The authors demonstrated that regionally reduced iodine-123-metaiodobenzylguanidine (I-MIBG) uptake in the inferior and septal left ventricular wall was present in 8 (47%) of 17 patients with Brugada syndrome but in non...

2015
Steven G. DuBois Susan Groshen Julie R. Park Daphne A. Haas-Kogan Xiaodong Yang Ethan Geier Eugene Chen Kathy Giacomini Brian Weiss Susan L. Cohn M. Meaghan Granger Gregory A. Yanik Randall Hawkins Jesse Courtier Hollie Jackson Fariba Goodarzian Hiroyuki Shimada Scarlett Czarnecki Denice Tsao-Wei Judith G. Villablanca Araz Marachelian Katherine K. Matthay

Purpose: I-metaiodobenzylguanidine (MIBG) is a radiopharmaceutical with activity in neuroblastoma. Vorinostat is a histone deacetylase inhibitor that has radiosensitizing properties. The goal of this phase I study was to determine the MTDs of vorinostat and MIBG in combination. Experimental Design: Patients 30 years with relapsed/refractory MIBG-avid neuroblastoma were eligible. Patients receiv...

Journal: :Circulation 1988
E B Henderson J K Kahn J R Corbett D E Jansen J J Pippin P Kulkarni V Ugolini M S Akers C Hansen L M Buja

I-123 metaiodobenzylguanidine (MIBG) is a new radiopharmaceutical with properties that allow the characterization of the sympathetic innervation of several organ systems. In this study, we used MIBG with tomographic imaging to evaluate noninvasively the differences in myocardial sympathetic innervation in 14 healthy volunteers and 16 patients with severe dilated cardiomyopathy (CM). Initial (15...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید